SCHEMBL8124584

SCHEMBL8124584

COc1cccc(N2CCC(CN)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.56
KCNH2 Q12809 2/20 0.55
DRD2 P14416 1/20 0.55
BPTF Q12830 1/20 0.54
MAPT P10636 3/20 0.52
NPC1 O15118 1/20 0.52
FFAR4 Q5NUL3 1/20 0.52
ADRA1D P25100 2/20 0.52
ADRA1A P35348 2/20 0.52
ADRA1B P35368 2/20 0.52
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
MEN1 O00255 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8123113 0.83 HRH4 (0.56) ADRB1DRD2MAPTADRA1DADRA1A
SCHEMBL20129611 0.83 ADRB1 (0.61) ADRB1KCNH2DRD2MAPTNPC1
Hydrochloric Acid SCHEMBL25307997 0.81 ADRB1 (0.59) ADRB1KCNH2DRD2MAPTNPC1
Hydrochloric Acid SCHEMBL30475416 0.81 ADRB1 (0.59) ADRB1KCNH2DRD2MAPTNPC1
SCHEMBL2093308 0.81 ADRB1 (0.63) ADRB1KCNH2DRD2MAPTNPC1
SCHEMBL2560547 0.80 FFAR4 (0.78) ADRB1KCNH2DRD2MAPTFFAR4
SCHEMBL11074672 0.80 ADRB1 (0.76) ADRB1KCNH2DRD2MAPTNPC1
SCHEMBL2093305 0.80 ADRB1 (0.61) ADRB1KCNH2DRD2MAPTNPC1
SCHEMBL23657145 0.80 ADRB1 (0.61) ADRB1KCNH2DRD2MAPTNPC1
Ammonia Solution, Strong SCHEMBL8124587 0.80 ADRB1 (0.61) ADRB1KCNH2DRD2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0717739-B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses KNOLL AG (DE) 2000-03-29 EP disclosed
US-5767116-A TREATING PSYCHOSES KNOLL ATKIENGESELLSCHAFT (DE) 1998-06-16 US disclosed
EP-0717739-A1 BICYCLIC AROMATIC COMPOUNDS AS THERAPEUTIC AGENTS Knoll AG (DE) 1996-06-26 EP disclosed
WO-1995007274-A1 BICYCLIC AROMATIC COMPOUNDS AS THERAPEUTIC AGENTS KNOLL AG (DE) 1995-03-16 WO disclosed